InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,175.60
(
0.67%
)
Dow Jones
39,357.01
(
-0.36%
)
Brent Oil
81.57
(
-0.05%
)
Bitcoin
59,266.70
(
-0.15%
)
Post# of 252864
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

floblu14

Send PM Follow Ignore
Followers 22
Posts 3682
Boards Moderated 0
Alias Born 07/20/2006

floblu14

Re: None

Monday, 09/14/2009 7:54:46 AM

Monday, September 14, 2009 7:54:46 AM

Post# of 252864
UPDATE 1-U.S. FDA to review Mylan's generic Copaxone
Mon Sep 14, 2009 7:38am EDT

Teva shares fall 3.8 percent in U.S.

Momenta Pharmaceuticals Inc (MNTA.O) said in July 2008 that the U.S. Food and Drug Administration had accepted its generic Copaxone application for review. Teva sued Momenta and partner Novartis AG (NOVN.VX) the following month for patent infringement.

http://www.reuters.com/article/rbssHealthcareNews/idUSN1449708220090914
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up